quinazolines has been researched along with Anemia, Cooley's in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Engel, JD; Fucharoen, S; Hongeng, S; Jearawiriyapaisarn, N; Kaewsakulthong, W; Khamphikham, P; Nualkaew, T; Paiboonsukwong, K; Pongpaksupasin, P; Songdej, D; Sripichai, O | 1 |
Byrnes, C; de Vasconcellos, JF; Dean, A; Kaushal, M; Krivega, I; Lee, YT; Miller, JL | 1 |
Eftyhiadis, E; Komninaka, V; Loukopoulos, D; Mantzourani, M; Terpos, E; Voskaridou, E | 1 |
3 other study(ies) available for quinazolines and Anemia, Cooley's
Article | Year |
---|---|
UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells.
Topics: beta-Thalassemia; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression; Hemoglobin E; Humans; Quinazolines | 2020 |
Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
Topics: Adult; Anemia, Sickle Cell; beta-Thalassemia; Cell Differentiation; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Erythroid Precursor Cells; Erythropoiesis; Fetal Hemoglobin; gamma-Globins; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; In Vitro Techniques; LIM Domain Proteins; Locus Control Region; Models, Biological; Promoter Regions, Genetic; Quinazolines; Transcription Factors | 2015 |
Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
Topics: Adult; Antisickling Agents; beta-Thalassemia; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Remission Induction; Thrombocytosis | 2002 |